These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7485033)
1. ANCA in IBD: nice, but necessary? Heiman DR; DiPalma JA Am J Gastroenterol; 1995 Nov; 90(11):2066-7. PubMed ID: 7485033 [No Abstract] [Full Text] [Related]
2. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Bansi DS; Chapman RW; Fleming KA Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455 [TBL] [Abstract][Full Text] [Related]
4. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease. Hartman C; Eliakim R; Shamir R Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261 [No Abstract] [Full Text] [Related]
5. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis. Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205 [TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related]
7. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease. Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041 [No Abstract] [Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Bartůnková J; Kolárová I; Sedivá A; Hölzelová E Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458 [TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]
10. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. Abad E; Tural C; Mirapeix E; Cuxart A J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879 [TBL] [Abstract][Full Text] [Related]
11. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?]. Folwaczny C; Fricke H Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690 [No Abstract] [Full Text] [Related]
12. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641 [TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure? Andreani ML; Frascà G; Brusco G; Borgnino L; Biagi F; Gasbarrini G; Corazza GR Ann Ital Med Int; 1996; 11(4):254-7. PubMed ID: 9050283 [TBL] [Abstract][Full Text] [Related]
16. [Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations]. Pintér M; Pintérová KM; Drahosová M; Rejchrt S; Douda T; Tachecí I; Kopácová M; Bures J Cas Lek Cesk; 2007; 146(11):863-7. PubMed ID: 18069213 [TBL] [Abstract][Full Text] [Related]
17. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis]. Wüthrich RP Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270 [TBL] [Abstract][Full Text] [Related]
18. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease]. Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421 [TBL] [Abstract][Full Text] [Related]